Literature DB >> 11672566

Basal tonic release of nitric oxide coupled to cGMP production regulates the vascular reactivity of the mesenteric bed.

S Buvinic1, J P Huidobro-Toro.   

Abstract

To reveal a basal production of nitric oxide (NO) and guanosine 3',5' cyclic monophosphate (cGMP) in the rat arterial mesenteric bed, mesenteries were perfused in the absence and in the presence of selective blockers of the L-arginine cascade. Endothelium removal or inhibition of NO synthase significantly reduced the release of NO and tissue cGMP. A significant correlation between these messengers was shown. Blockade of soluble guanylyl cyclase with 0.3-10 microM 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) only reduced basal cGMP production; 1-100 nM sildenafil (Sild), an inhibitor of phosphodiesterase V, increased basal tissue cGMP without modifying the release of NO. Acetylcholine (0.01-10 microM) caused a concentration-dependent rise in NO and cGMP evoking a proportional vasodilatation, demonstrating the interdependence between these messengers and vascular reactivity. Endothelium removal or NO synthase blockade reduced the acetylcholine-induced increase of messengers and the vasodilatation. ODQ attenuated only the increase in cGMP and the vasodilatation, while sildenafil increased cGMP without significantly altering luminal NO release. The present results highlight a tonic release of NO and its involvement in endothelial-smooth muscle signaling; NO and cGMP are determinants of vascular reactivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672566     DOI: 10.1016/s0014-2999(01)01165-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.

Authors:  Nur Başak Sürmeli; Frederike M Müskens; Michael A Marletta
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

2.  Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed.

Authors:  Inés M Poblete; María Luz Orliac; René Briones; Edda Adler-Graschinsky; J Pablo Huidobro-Toro
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

3.  Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.

Authors:  X F Figueroa; M I Poblete; M P Boric; V E Mendizábal; E Adler-Graschinsky; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP.

Authors:  Stephen P L Cary; Jonathan A Winger; Michael A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

5.  Mitigation of indomethacin-induced gastric mucosal lesions by a potent specific type V phosphodiesterase inhibitor.

Authors:  Kemal Karakaya; Volkan Hanci; Sibel Bektas; Murat Can; Hamdi-B Ucan; Ali-Ugur Emre; Oge Tascilar; Isil Ozkocak Turan; Mustafa Comert; Oktay Irkorucu; Guldeniz Karadeniz Cakmak
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

6.  P2Y1 and P2Y2 receptor distribution varies along the human placental vascular tree: role of nucleotides in vascular tone regulation.

Authors:  Sonja Buvinic; M Inés Poblete; M Verónica Donoso; Ana María Delpiano; René Briones; Ramiro Miranda; J Pablo Huidobro-Toro
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

7.  P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.

Authors:  Sonja Buvinic; René Briones; J Pablo Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

8.  Increased ATP and ADO Overflow From Sympathetic Nerve Endings and Mesentery Endothelial Cells Plus Reduced Nitric Oxide Are Involved in Diabetic Neurovascular Dysfunction.

Authors:  M Verónica Donoso; M Jesús Mascayano; Inés M Poblete; J Pablo Huidobro-Toro
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.